tirzepatide and semaglutide mechanism of action The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment type 2 diabetes mellitus obesity Genetic variations tied to effectiveness

same thyroid precautions apply Liraglutide (Saxenda): Another GLP-1 agonist with daily dosing

NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function

The real key is going to be side effects over time, if retatrutide is like other drugs in the class then the side effects should decrease with time, but unfortunately, we dont have that today, at this point I have some questions and minor concerns but without the data over time its hard to speculate about tolerability further beyond saying its similar to other drugs in the class

Track any improvements in symptoms, changes in energy levels, or any new side effects

Kabisch 1 , C